Investigators were able to halt the growth of glioblastoma, an aggressive form of brain cancer, by inhibiting an enzyme called CDK5, according to a Northwestern Medicine study published in Cell Reports. The discovery of this enzyme’s regulatory influence on glioblastoma may open the door to a long-awaited improvement upon current therapy options, according to Subhas